Evidence map›Paper›PMID 42458071›Full record

ArticleEMBO reports2026

Caspase-3 cleaves CYLD to restrict interferon signaling during mitochondrial apoptosis.

Yanis M Macé, Tiphaine Douanne, Jane Jardine, Kilian Trillet, Rosalie Moreau, Joanna Re, Cara J Ellison, Nadine Laguette, Paul R Elliott, Julie Gavard and 1 more

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yanis M MacéTeam SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France.
Tiphaine DouanneTeam SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France.ORCID http://orcid.org/0000-0001-8197-8358
Jane JardineTeam SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France.
Kilian TrilletTeam SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France.ORCID http://orcid.org/0000-0003-0749-9871
Rosalie MoreauTeam SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France.
Joanna ReInstitut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS UMR5535, Montpellier, France.
Cara J EllisonDepartment of Biochemistry, University of Oxford, Oxford, UK.
Nadine LaguetteInstitut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS UMR5535, Montpellier, France.ORCID http://orcid.org/0000-0001-8072-5607
Paul R ElliottDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-7641-2103
Julie GavardTeam SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France.
Nicolas BidèreTeam SOAP, CRCI²NA, INSERM, CNRS, Université de Nantes, Nantes, France. nicolas.bidere@inserm.fr.ORCID http://orcid.org/0000-0001-9177-0008

Funding

EC | European Research Council (ERC) SENTINEL 101087092Fondation ARC pour la Recherche sur le Cancer (ARC) PJA2024070008542Fondation de France (Fondationfrance) Jane JardineInstitut National Du Cancer (INCa) INCa_18384Institut National Du Cancer (INCa) INCa PAIR-CEREB lNCa_16285Institut National Du Cancer (INCa) SIRIC ILIAD INCA-DGOS-INSERM-ITMO Cancer_18011Ligue Contre le Cancer (laliguecancer) comités de Loire-Atlantique,Maine et Loire,Vendée,Ille et Vilaine,Mayenne,FinistèreLigue Contre le Cancer (laliguecancer) Equipe labellisée
6 · The paper itself

Abstract

Mitochondrial outer membrane permeabilization is a pivotal event in programmed cell death by apoptosis, leading to the activation of the cysteine protease caspase-3 (CASP3) and the release of mitochondrial nucleic acids. This release triggers the activation of the Interferon Regulatory Factor 3 (IRF3) transcription factor and the subsequent IRF3-mediated type I interferon production and cell death. CASP3 ensures apoptosis remains immunologically silent, though the mechanisms are unclear. We report that CASP3 cleaves CYLD, a deubiquitinating enzyme crucial for cell fate and inflammatory signaling. This proteolysis occurs at a site distinct from the previously reported CASP8 site, which is involved in limiting cell lysis and inflammation during extrinsic apoptosis. Although cleaved CYLD retains its enzymatic activity in vitro, knocked-in cells expressing CASP3-resistant CYLD show increased interferon signaling and enhanced cell death. Thus, a proteolytic code regulates CYLD to balance inflammation during programmed cell death.

Indexed as

ApoptosisCaspase 3InterferonsMitochondriaSignal TransductionAnimalsDeubiquitinating Enzyme CYLDHumansInterferon Regulatory Factor-3Interferon Type IProteolysisCaspase 3CYLD protein, humanDeubiquitinating Enzyme CYLDInterferon Regulatory Factor-3InterferonsInterferon Type I

Identifiers

PMID42458071
PMCPMC13554258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.